Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$2.14 - $3.43 $780,036 - $1.25 Million
-364,503 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$2.2 - $6.01 $342,093 - $934,536
-155,497 Reduced 29.9%
364,503 $1.1 Million
Q4 2021

Feb 14, 2022

BUY
$6.0 - $9.92 $900,000 - $1.49 Million
150,000 Added 40.54%
520,000 $3.35 Million
Q3 2021

Nov 15, 2021

BUY
$6.98 - $12.03 $2.58 Million - $4.45 Million
370,000 New
370,000 $2.62 Million

Others Institutions Holding SRZN

About Surrozen, Inc.


  • Ticker SRZN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,122,900
  • Market Cap $371M
  • Description
  • Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, a...
More about SRZN
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.